Center Laboratories (4123) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.002x

Based on the latest financial reports, Center Laboratories (4123) has a cash flow conversion efficiency ratio of 0.002x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$46.61 Million ≈ $1.47 Million USD) by net assets (NT$19.64 Billion ≈ $618.69 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Center Laboratories fund operations to measure how many days the company can operate on defensive assets alone.

Center Laboratories - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Center Laboratories's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Center Laboratories Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Center Laboratories ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Patriot Battery Metals Inc AU:PMT	0.001x
Decai Decoration Co Ltd SHG:605287	0.009x
Kyobo Securiti KO:030610	0.054x
Xvivo Perfusion AB ST:XVIVO	0.030x
Lenzing Aktiengesellschaft VI:LNZ	0.071x
Janux Therapeutics Inc NASDAQ:JANX	-0.013x
Hnac Technology Co Ltd SHE:300490	0.023x
Myers Industries Inc NYSE:MYE	0.091x

Annual Cash Flow Conversion Efficiency for Center Laboratories (2006–2024)

The table below shows the annual cash flow conversion efficiency of Center Laboratories from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see 4123 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	NT$18.05 Billion ≈ $568.82 Million	NT$415.71 Million ≈ $13.10 Million	0.023x	+148.32%
2023-12-31	NT$20.22 Billion ≈ $636.92 Million	NT$-963.44 Million ≈ $-30.35 Million	-0.048x	-383.21%
2022-12-31	NT$19.25 Billion ≈ $606.55 Million	NT$-189.88 Million ≈ $-5.98 Million	-0.010x	+41.91%
2021-12-31	NT$21.09 Billion ≈ $664.61 Million	NT$-358.14 Million ≈ $-11.28 Million	-0.017x	-29.96%
2020-12-31	NT$20.63 Billion ≈ $650.10 Million	NT$-269.56 Million ≈ $-8.49 Million	-0.013x	+29.50%
2019-12-31	NT$15.46 Billion ≈ $487.02 Million	NT$-286.45 Million ≈ $-9.02 Million	-0.019x	-146.39%
2018-12-31	NT$15.47 Billion ≈ $487.30 Million	NT$617.84 Million ≈ $19.47 Million	0.040x	-66.54%
2017-12-31	NT$16.87 Billion ≈ $531.48 Million	NT$2.01 Billion ≈ $63.44 Million	0.119x	+63.44%
2016-12-31	NT$15.82 Billion ≈ $498.51 Million	NT$1.16 Billion ≈ $36.41 Million	0.073x	+886.07%
2015-12-31	NT$14.88 Billion ≈ $468.92 Million	NT$-138.29 Million ≈ $-4.36 Million	-0.009x	-754.87%
2014-12-31	NT$6.94 Billion ≈ $218.54 Million	NT$-7.54 Million ≈ $-237.52K	-0.001x	-113.13%
2013-12-31	NT$5.01 Billion ≈ $157.93 Million	NT$41.50 Million ≈ $1.31 Million	0.008x	+77.01%
2012-12-31	NT$3.47 Billion ≈ $109.32 Million	NT$16.23 Million ≈ $511.33K	0.005x	-85.23%
2011-12-31	NT$2.21 Billion ≈ $69.75 Million	NT$70.11 Million ≈ $2.21 Million	0.032x	+1890.25%
2010-12-31	NT$2.18 Billion ≈ $68.76 Million	NT$-3.86 Million ≈ $-121.64K	-0.002x	-109.56%
2009-12-31	NT$2.11 Billion ≈ $66.57 Million	NT$39.11 Million ≈ $1.23 Million	0.019x	-76.35%
2008-12-31	NT$573.09 Million ≈ $18.06 Million	NT$44.86 Million ≈ $1.41 Million	0.078x	-45.54%
2007-12-31	NT$471.17 Million ≈ $14.84 Million	NT$67.71 Million ≈ $2.13 Million	0.144x	+1.12%
2006-12-31	NT$273.07 Million ≈ $8.60 Million	NT$38.81 Million ≈ $1.22 Million	0.142x	--

About Center Laboratories

TWO:4123 Taiwan Drug Manufacturers - Specialty & Generic

Market Cap

$863.72 Million

NT$27.41 Billion TWD

Market Cap Rank

#9718 Global

#333 in Taiwan

Share Price

NT$37.15

Change (1 day)

+0.27%

52-Week Range

NT$33.60 - NT$49.35

All Time High

NT$236.72